— § 02
What the literature shows.
Skin endpoints in oral form
—
No defensible peer-reviewed RCTs on oral exosomes for skin in humans. The clinical exosome literature is overwhelmingly injectable / topical, not oral.
10%
Bioavailability of oral exosomes
Mechanistic concerns
Exosomes are vesicular structures unlikely to survive gastric digestion intact. The mechanism by which they would deliver a skin endpoint orally is not established.
5%
Topical / clinic exosome therapeutics
Promising small trials
An entirely different category — and not what you are buying when you buy a beverage.
55%
Marketing 'cellular renewal' claims
—
Aspirational language with no defensible mechanism in the oral form.
5%